Trials / Unknown
UnknownNCT00422331
Safety and Efficacy Study of Lithium in Bipolar Disorder
Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Lithium in Bipolar I Disorder
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 206 (estimated)
- Sponsor
- JDS Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Lithium is safe and effective in the treatment of Bipolar I Disorder subjects with symptoms of acute mania.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lithium Carbonate Capsule |
Timeline
- Start date
- 2007-01-01
- Completion
- 2007-12-01
- First posted
- 2007-01-15
- Last updated
- 2007-08-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00422331. Inclusion in this directory is not an endorsement.